Authors must agree to allow publication of accepted abstract(s) in the Journal of Thoracic Oncology (JTO) and the conference website. Honolulu, Language : If there is any question regarding similarity to earlier work or possible duplication or redundancy, it is The deadline to claim credit for this course Collaborate with other professionals in the field. 
Higher resolution is acceptable and preferred. * ATS members from Low Middle-Income Countries (LMIC) are eligible to receive a thirty percent discount on general registration, postgraduate courses, meet the expert and medical education seminars. YEN CHUNG, https://doi.org/10.1016/j.chest.2022.08.010, https://doi.org/10.1016/j.chest.2022.08.011, https://doi.org/10.1016/j.chest.2022.08.012, MONICA KRAFT, GENE L COLICE, CHRISTOPHER AMBROSE, WILLIAM COOK, STEPHANIE L ROSETI, https://doi.org/10.1016/j.chest.2022.08.013, https://doi.org/10.1016/j.chest.2022.08.014, ANDREW MENZIES-GOW, MARK GURNELL, NJIRA L LUGOGO, LIAM G HEANEY, WILLIAM COOK, https://doi.org/10.1016/j.chest.2022.08.015, PEDRO A LAMOTHE, MARTIN C RUNNSTROM, NATALIA SMIRNOVA, FRANCES E LEE, https://doi.org/10.1016/j.chest.2022.08.016, YUTONG DONG, ALLISON GRECO, BHASKARA V GARIMELLA, BRITTA KUMLEY, https://doi.org/10.1016/j.chest.2022.08.017, ANAS MAHMOUD, BROOKE KANIA, DENIZ YUCEL, AHMED SALEM, SHIVANCK UPADHYAY, https://doi.org/10.1016/j.chest.2022.08.018, JONATHAN CORREN, MICHAEL E WECHSLER, GEOFFREY L CHUPP, CHRISTOPHER AMBROSE, GENE L COLICE, https://doi.org/10.1016/j.chest.2022.08.019, NASLOON ALI, STEPHANIE CHEN, TRUNG N TRAN, WILLIAM COOK, DAVID B PRICE, https://doi.org/10.1016/j.chest.2022.08.020, https://doi.org/10.1016/j.chest.2022.08.021, NICOLA A HANANIA, MONICA LITTLEJOHN, ARPAMAS SEETASITH, BENJAMIN TRZASKOMA, THOMAS CASALE, https://doi.org/10.1016/j.chest.2022.08.022, MARIO CASTRO, WILLIAM COOK, CHRISTOPHER AMBROSE, ANDREW W LINDSLEY, SANDHIA PONNARAMBIL, https://doi.org/10.1016/j.chest.2022.08.023, NJIRA L LUGOGO, PRAVEEN AKUTHOTA, SAMEER K MATHUR, AUTUMN BURNETTE, BENJAMIN EMMANUEL, https://doi.org/10.1016/j.chest.2022.08.024, JARED N SILVER, ARIJITA DEB, ELIZABETH R PACKNETT, DONNA MCMORROW, MICHAEL BOGART, https://doi.org/10.1016/j.chest.2022.08.025, https://doi.org/10.1016/j.chest.2022.08.026, GURJOT GARCHA, TULSI SHAH, RAMEEZ RAO, MARY K REISCHMANN, https://doi.org/10.1016/j.chest.2022.08.027, BARBARA P YAWN, JONATHAN N. TOBIN, JO ANN BROOKS, KENNETH MENDEZ, DAVID A BEUTHER, https://doi.org/10.1016/j.chest.2022.08.028, MIGUEL J LANZ, MICHAEL POLLACK, ILEEN GILBERT, HITESH N GANDHI, NJIRA L LUGOGO, https://doi.org/10.1016/j.chest.2022.08.029, NJIRA L LUGOGO, MICHAEL POLLACK, ILEEN GILBERT, HITESH N GANDHI, MIGUEL J LANZ, https://doi.org/10.1016/j.chest.2022.08.030, REYNOLD A PANETTIERI, BRADLEY E CHIPPS, RICHARD BEASLEY, ELLIOT ISRAEL, ALBERTO PAPI, https://doi.org/10.1016/j.chest.2022.08.031, https://doi.org/10.1016/j.chest.2022.08.032, https://doi.org/10.1016/j.chest.2022.08.033, AZZAM PAROYA, BRIANNE NAVETTA-MODROV, PAUL STRACHAN, https://doi.org/10.1016/j.chest.2022.08.034, https://doi.org/10.1016/j.chest.2022.08.035, ANOOPA MATHEW, KEVSER AKYUZ, RANIM CHAMSEDDIN, MUHAMMAD T KASHLAN, https://doi.org/10.1016/j.chest.2022.08.036, VAIBHAV AHLUWALIA, HASAN AHMAD HASAN ALBITAR, VIBHOR DR AHLUWALIA, VIVEK N IYER, https://doi.org/10.1016/j.chest.2022.08.037, https://doi.org/10.1016/j.chest.2022.08.038, PALAK RATH, STERLING SHRIBER, ANDREI HASTINGS, TANYA C MARSHALL, INDERPRIT SINGH, https://doi.org/10.1016/j.chest.2022.08.039, https://doi.org/10.1016/j.chest.2022.08.041, https://doi.org/10.1016/j.chest.2022.08.042, https://doi.org/10.1016/j.chest.2022.08.043, KEVIN LOUDERMILK, WHITTNEY WARREN, MICHAL J SOBIESZCZYK, MICHAEL J MORRIS, ROBERT J WALTER, https://doi.org/10.1016/j.chest.2022.08.044, HOLLIS R ONEAL, ROYA SHEYBANI, HENRY TK TSE, AJAY M SHAH, CHRISTOPHER B THOMAS, https://doi.org/10.1016/j.chest.2022.08.045, LYDIA BEDERKA, JENNIFER REBELES, XAVIER T REVELES, VIVIENNE I REBEL, https://doi.org/10.1016/j.chest.2022.08.047, CAROLINA VIGNA, AMMARA A WATKINS, ELLIOT L SERVAIS, CAMERON STOCK, https://doi.org/10.1016/j.chest.2022.08.048, MEAGHAN BRODERICK, RYAN PETTIT, LEO OTAKE, MIA KAZANJIAN, MICHAEL I EBRIGHT, https://doi.org/10.1016/j.chest.2022.08.049, ARA KLIJIAN, MOHAMMED G. AL JANABI, KIAN BAGHERI, KAVEH BAGHERI, https://doi.org/10.1016/j.chest.2022.08.050, https://doi.org/10.1016/j.chest.2022.08.051, BALAJI PRASAD ELLAPPAN MOHANAKRISHNAN, SARIA TASNIM, THIEN VO, RAJEEV GULATI, https://doi.org/10.1016/j.chest.2022.08.052, https://doi.org/10.1016/j.chest.2022.08.053, SAYYED MUHAMMAD ALI ABBAS ZAIDI, MANSUR ASSAAD, NOORE FATIMA, MAHEEN ANWAR, https://doi.org/10.1016/j.chest.2022.08.054, AHAMED KHALYFA, MATEUSZ D GORECKI, DAVID D GABBERT, HIMANSHU OHRI, https://doi.org/10.1016/j.chest.2022.08.055, https://doi.org/10.1016/j.chest.2022.08.056, https://doi.org/10.1016/j.chest.2022.08.057, MARC ASSAAD, DANY E ELSAYEGH, RACHA ABI MELHEM, KHALIL EL GHARIB, AHMAD ABOU YASSINE, https://doi.org/10.1016/j.chest.2022.08.058, ROCIO CASTILLO-LARIOS, ALEJANDRA YU LEE-MATEUS, DANIEL HERNANDEZ, SAI PRIYANKA PULIPAKA, IAN MAKEY, https://doi.org/10.1016/j.chest.2022.08.059, BARBARA H JOHNSON, PRANJAL TEWARI, MOSADOLUWA AFOLABI, WALTER A DANKER, https://doi.org/10.1016/j.chest.2022.08.060, HUZEFA BHOPALWALA, VINAYAK MISHRA, AMRIN M KHARAWALA, NAKEYA DEWASWALA, ADNAN BHOPALWALA, https://doi.org/10.1016/j.chest.2022.08.061, https://doi.org/10.1016/j.chest.2022.08.062, SARIA TASNIM, OLA AL-JOBORY, AHMAD HALLAK, MANISH L PATEL, https://doi.org/10.1016/j.chest.2022.08.063, KENNETH P SEASTEDT, DANIEL OSPINA-DELGADO, JENNIFER L WILSON, SIDHU P GANGADHARAN, https://doi.org/10.1016/j.chest.2022.08.064, LUKE M MEYER, AKRUTI P PRABHAKAR, PALANIAPPAN G MUTHAPPAN, https://doi.org/10.1016/j.chest.2022.08.065, https://doi.org/10.1016/j.chest.2022.08.066, https://doi.org/10.1016/j.chest.2022.08.067, SUMIT PATEL, RYAN FARHAT, WESTON E BOWKER, SALLY A SULIMAN, CORDEL FUHER, https://doi.org/10.1016/j.chest.2022.08.068, https://doi.org/10.1016/j.chest.2022.08.069, MARTIN SCHOEN, BRENDAN T HEIDEN, DANIEL B EATON, SU-HSIN CHANG, VARUN PURI, https://doi.org/10.1016/j.chest.2022.08.070, SCOTT R MOORE, MUHANNAD ANTOUN, RAJIT PAHWA, MADHAVI KANNEGANTI, AARON ABRAMOVITZ, https://doi.org/10.1016/j.chest.2022.08.071, https://doi.org/10.1016/j.chest.2022.08.072, JORGE A RUIZ DE SOMOCURCIO, SIDHU P GANGADHARAN, ADNAN MAJID, MIHIR PARIKH, JENNIFER L WILSON, https://doi.org/10.1016/j.chest.2022.08.073, AHAMED KHALYFA, SHIL U PUNATAR, DAVID D GABBERT, HIMANSHU OHRI, https://doi.org/10.1016/j.chest.2022.08.074, AMOGH NADKARNI, JEEL GALA, NINA AMILINENI, https://doi.org/10.1016/j.chest.2022.08.075, https://doi.org/10.1016/j.chest.2022.08.076, SIVA NAGA S YARRARAPU, JAYASREE RAVILLA, GAURAV MOHAN, CHARMEE VYAS, DAVID ANWAR, https://doi.org/10.1016/j.chest.2022.08.077, https://doi.org/10.1016/j.chest.2022.08.078, JERRIN BAWA, DOREEN KHAKSHOUR, JOEL R SILVERMAN, JASON HOURIZADEH, https://doi.org/10.1016/j.chest.2022.08.079, OGENETEGA J MADEDOR, DANIEL F SUMMERS, LIAM R SULLIVAN, https://doi.org/10.1016/j.chest.2022.08.080, KHYATI KHATTAR, PURVESHKUMAR PATEL, TAPAN BUCH, DHARA PATEL, BRIHANT SHARMA, https://doi.org/10.1016/j.chest.2022.08.081, https://doi.org/10.1016/j.chest.2022.08.082, NITASA SAHU, DELINE DA COSTA, DUSTIN MANCHESTER, https://doi.org/10.1016/j.chest.2022.08.084, KATHLEEN CAPACCIONE, CONNIE LIOU, MARY M SALVATORE, https://doi.org/10.1016/j.chest.2022.08.085, AMAD CHOHAN, GRIFFIN REED, SANDEEP AREPALLY, ALBERT MANUDHANE, CHRISTOPHER F ALLISON, https://doi.org/10.1016/j.chest.2022.08.086, https://doi.org/10.1016/j.chest.2022.08.087, LAURA BRADEL, UMA YOGANATHAN, MOHAMED MANAA, JOHN YAVORSKI, KENT STEPHENSON, https://doi.org/10.1016/j.chest.2022.08.088, ZACHARY A BANBURY, ABDULLAH AHMAD, RO-KAYE A SIMMONDS, ENRIQUE BAEZ, ADAM G ARNOFSKY, https://doi.org/10.1016/j.chest.2022.08.089, DALE C LONG, VAMSIDHAR NARAPARAJU, PRASHANT GROVER, ROBERT C GALLAGHER, ATIQUE MIRZA, https://doi.org/10.1016/j.chest.2022.08.090, https://doi.org/10.1016/j.chest.2022.08.091, JOHN TREMBLAY, MIKHAIL TOROSOFF, MARC JUDSON, https://doi.org/10.1016/j.chest.2022.08.092, AMBREEN SHAHZADI, SALMA KHAN, ZINOBIA KHAN, MOSES BACHAN, https://doi.org/10.1016/j.chest.2022.08.093, https://doi.org/10.1016/j.chest.2022.08.094, ANDRES M CORDOVA SANCHEZ, KUNAL BHUTA, SUBASH NEPAL, DEBANIK CHAUDHURI, https://doi.org/10.1016/j.chest.2022.08.095, OLIVIA MILLAY, TAHA AHMED, ADRIAN W MESSERLI, https://doi.org/10.1016/j.chest.2022.08.096, NANG SAN HTI LAR SENG, NAY MIN TUN, THWE THWE TUN, RAKESH MAHALI, https://doi.org/10.1016/j.chest.2022.08.097, MUBASHIR AYAZ AHMED, SHAYET HOSSAIN ESHAN, SAMI HUSSEIN, CHENYU SUN, NINA OGUAMANAM, https://doi.org/10.1016/j.chest.2022.08.098, SHELBY SCHUH, TARANG PATEL, SACHIN M PATIL, MOHAMMED ALNIJOUMI, https://doi.org/10.1016/j.chest.2022.08.099, KEVSER AKYUZ, RANIM CHAMSEDDIN, ABDULLAH YESILYAPRAK, VERISHA KHANAM, ZAIN I KULAIRI, https://doi.org/10.1016/j.chest.2022.08.100, MARC ERICKSON, HARIKA YADAV, JORDAN D AUSTIN, JOSHUA DAVIS, HARISH MANYAM, https://doi.org/10.1016/j.chest.2022.08.101, OLUSHOLA O OGUNLEYE, JAMALUDDIN SAEED, MIRGHANI I ALI, SHALIN J PATEL, https://doi.org/10.1016/j.chest.2022.08.102, SREEKARI KEDARISETTI, DIVYA RAJMOHAN, YAOYUN SHEN, ASHOK KHANNA, MARINA M MARGULIS, https://doi.org/10.1016/j.chest.2022.08.103, KOUSHIK SANKU, JEETENDRA B PATEL, VINDHYA SRIRAMOJU, THARUN BANDARUPALLI, https://doi.org/10.1016/j.chest.2022.08.104, ADAM ADAM, CHEN CHAO, MOSES BACHAN, ZINOBIA KHAN, https://doi.org/10.1016/j.chest.2022.08.105, https://doi.org/10.1016/j.chest.2022.08.106, https://doi.org/10.1016/j.chest.2022.08.107, SZE JIA NG, HUI CHONG LAU, JONATHAN FINKEL, https://doi.org/10.1016/j.chest.2022.08.108, AKANKSHA MEHLA, MUNIS AHMED, RIDHAM PATEL, BEEBARG RAZA, Education, Research, and Quality Improvement, Occupational and Environmental Lung Diseases, Pulmonary Manifestations of Systemic Disease, select article CHEST Annual Meeting 2022 October 16-19, 2022, CHEST Annual Meeting 2022 October 16-19, 2022, select article EFFECTS OF BENRALIZUMAB ON AIRWAY DYNAMICS IN SEVERE EOSINOPHILIC ASTHMA USING FUNCTIONAL RESPIRATORY IMAGING PARAMETERS: THE BURAN STUDY DESIGN, EFFECTS OF BENRALIZUMAB ON AIRWAY DYNAMICS IN SEVERE EOSINOPHILIC ASTHMA USING FUNCTIONAL RESPIRATORY IMAGING PARAMETERS: THE BURAN STUDY DESIGN, select article LONG-TERM REAL-WORLD EFFECTIVENESS OF BENRALIZUMAB IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA: RESULTS FROM THE ZEPHYR 2 STUDY, LONG-TERM REAL-WORLD EFFECTIVENESS OF BENRALIZUMAB IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA: RESULTS FROM THE ZEPHYR 2 STUDY, select article A CASE OF AUTOSOMAL-DOMINANT HYPER-IGE SYNDROME MASQUERADING AS CYSTIC FIBROSIS, A CASE OF AUTOSOMAL-DOMINANT HYPER-IGE SYNDROME MASQUERADING AS CYSTIC FIBROSIS, select article EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA GROUPED BY NUMBER OF ADDITIONAL ASTHMA CONTROLLER MEDICATIONS: RESULTS FROM THE PHASE 3 NAVIGATOR STUDY, EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA GROUPED BY NUMBER OF ADDITIONAL ASTHMA CONTROLLER MEDICATIONS: RESULTS FROM THE PHASE 3 NAVIGATOR STUDY, select article WAYFINDER: A PHASE 3B, SINGLE-ARM STUDY TO EVALUATE THE EFFICACY AND SAFETY OF TEZEPELUMAB IN REDUCING ORAL CORTICOSTERIODS (OCS) USE IN OCS-DEPENDENT PATIENTS WITH SEVERE ASTHMA, WAYFINDER: A PHASE 3B, SINGLE-ARM STUDY TO EVALUATE THE EFFICACY AND SAFETY OF TEZEPELUMAB IN REDUCING ORAL CORTICOSTERIODS (OCS) USE IN OCS-DEPENDENT PATIENTS WITH SEVERE ASTHMA, select article MORE THAN MEETS THE EYE: A CASE OF DUPILUMAB-ASSOCIATED UVEITIS, MORE THAN MEETS THE EYE: A CASE OF DUPILUMAB-ASSOCIATED UVEITIS, select article CASE REPORT OF ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS IN A PATIENT WITHOUT ASTHMA OR BRONCHIECTASIS, CASE REPORT OF ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS IN A PATIENT WITHOUT ASTHMA OR BRONCHIECTASIS, select article MYASTHENIA GRAVIS PRECIPITATED BY ASYMPTOMATIC COVID-19 INFECTION, VACCINE, OR BOTH? Abstracts should be organized in different sections based on the selected abstract type. No, there is no charge to submit an abstract to WCLC. Dr. Rifkin will present the session, Appropriate Evaluation and Management of Non-Low Risk Chest Pain Patients, on Friday, April 21, 2023, from 3:30 p.m. to 4:30 p.m. Dr. Rifkin will present the session, Appropriate Evaluation and Management of Non-Low Risk Chest Pain Patients, on Friday, April 21, 2023, from 3:30 p.m. to 4:30 p.m. The 26th China Cardiovascular Intervention Rorum and the 12th China Chest Pain Centers Conference (CCIF&CCPCC2023) will meet you in Xi'an, from April 20th to Fellow case reports: Open only to those enrolled in a physician training program, both domestic and international. | VISIT THE CHEST 2023 WEBSITE . Tuesday 16 May 2023. By continuing you are agreeing to our privacypolicy. WebCHEST 2023 will bring you the most up-to-date education in clinical pulmonary, sleep, and critical care medicine through simulation sessions, original research presentations, interactive games, and so much more. Abstracts (original investigations): Open to all health care professionals, both domestic and international. Publication: Authors must agree to allow publication of accepted abstract(s) in the Journal of Thoracic Oncology (JTO) and the conference website. Please note that times are subject to change. Reserve your spot in the CHEST Exhibit Hall to connect with thousands of clinicians who are interested in hearing about new ideas, approaches, and products in chest medicine. Presenters are limited to 2 oral presentations. Would it be possible to submit an abstract without results and conclusion? Friday, October 13 7:30 am - 12 pm. Nearly 2,000 abstracts and case reports were presented at CHEST 2022, with clinicians from 85 countries represented. This conference is sponsored by the American Thoracic Society, the Washington Thoracic Society and the American Lung Association in Washington. There is no limit to the number of abstracts in which an author can be lead author. Industry/pharmaceutical/commercial authors are permitted to present e-poster presentations. The 33rd Annual Washington Thoracic Society (WTS) Chest Disease Conference is designed to cover a broad spectrum of clinical pulmonary and critical care topics geared towards physicians and allied health professionals in pulmonary and critical care medicine, thoracic surgery, allergy, infectious disease, family practice and internal medicine. Join CHEST, October 8 to 11, in Hawaii, at the Hawaii Convention Center in Honolulu. Is there any charge for the submission of abstracts, and if so, how much is it? Atlanta is a city known for its vibrant history and modern progress in equity and inclusion in transportation and beyond. Explanation of why the abstract qualifies aslate-breaking(including the endpoints for which data will be provided and the date for which the abstract will be updated prior to the LBA final submission deadline on June 16, 2023). Expand your reach. April 4-6, 2016 Philadelphia, USA. Resort & Conv. Date : 19/05/2023 ; 630 0 . Enhance your CV by applying for a scientific presentation award. For late-breaking abstracts, does the Conference only permit abstracts that report on Phase 3 [and higher] studies? 5601 6th Ave S, Ste 460 Seattle, WA 98117 T:206-441-5100. Presented abstracts will be judged by session moderators, and award recipients will be selected for their outstanding original scientific research. Penalties for plagiarism may include:Rejection of abstract, and/or author(s) banned from making presentations at IASLC conferences. The presenting author registration deadline is July 14, 2023. June 17, 2023 CLICK HERE to Register for the June 17, 2023 Conference September 9, 2023 CLICK HERE to Register for the September 9, 2023 Conference Refund Policy Requests for cancellation must be submitted to cmepd@louisville.edu two weeks before the program start date. Are there restrictions towards pharmaceutical/commercial authors on presenting abstracts at the meeting? Schedule for TCHES Volume 2023/1 15 July 2022 Submission deadline 2226 For reference, here is a link to the disclosure form. Tables:No limit; each table counts as 100 words. WebCHEST Annual Meeting 2023. Most abstracts will be published and released prior to the meeting, except for embargoed abstracts which will be posted on the day of presentation. This would include LDCT and radiology but also ongoing research into other methods and technologies to screen and detect thoracic cancers early. Yes, we do allow the submission of case reports. HOW GENETIC PREDISPOSITION AND IMMUNE RESPONSES PLAY A ROLE IN THE NEUROMUSCULAR JUNCTION, select article EFFICACY OF TEZEPELUMAB IN PATIENTS WITH UNCONTROLLED ASTHMA DESPITE RECEIVING TREATMENT FOR MODERATE OR SEVERE DISEASE: POOLED ANALYSIS OF PATHWAY AND NAVIGATOR STUDIES, EFFICACY OF TEZEPELUMAB IN PATIENTS WITH UNCONTROLLED ASTHMA DESPITE RECEIVING TREATMENT FOR MODERATE OR SEVERE DISEASE: POOLED ANALYSIS OF PATHWAY AND NAVIGATOR STUDIES, select article CLINICAL OUTCOMES AND EMERGENCY HEALTH CARE UTILIZATION IN PATIENTS WITH SEVERE ASTHMA WHO CONTINUED, SWITCHED, OR STOPPED BIOLOGIC THERAPY: RESULTS FROM THE CLEAR STUDY, CLINICAL OUTCOMES AND EMERGENCY HEALTH CARE UTILIZATION IN PATIENTS WITH SEVERE ASTHMA WHO CONTINUED, SWITCHED, OR STOPPED BIOLOGIC THERAPY: RESULTS FROM THE CLEAR STUDY, select article CLINICAL OUTCOMES IN PATIENTS WITH SEVERE ASTHMA WHO HAD OR HAD NOT INITIATED BIOLOGIC THERAPY: RESULTS FROM THE CLEAR STUDY, CLINICAL OUTCOMES IN PATIENTS WITH SEVERE ASTHMA WHO HAD OR HAD NOT INITIATED BIOLOGIC THERAPY: RESULTS FROM THE CLEAR STUDY, select article REDUCTIONS IN EXACERBATIONS AND HOSPITALIZATIONS ARE SIMILAR ACROSS DIFFERENT OMALIZUMAB DOSING REGIMENS, REDUCTIONS IN EXACERBATIONS AND HOSPITALIZATIONS ARE SIMILAR ACROSS DIFFERENT OMALIZUMAB DOSING REGIMENS, select article EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA BY SMOKING HISTORY: POST HOC ANALYSIS OF THE PHASE 3 NAVIGATOR STUDY, EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA BY SMOKING HISTORY: POST HOC ANALYSIS OF THE PHASE 3 NAVIGATOR STUDY, select article PASSAGE: A PHASE 4, SINGLE-ARM, OPEN-LABEL STUDY TO EVALUATE THE EFFECTIVENESS AND SAFETY OF TEZEPELUMAB IN PATIENTS WITH SEVERE ASTHMA, INCLUDING UNDER-REPRESENTED GROUPS, PASSAGE: A PHASE 4, SINGLE-ARM, OPEN-LABEL STUDY TO EVALUATE THE EFFECTIVENESS AND SAFETY OF TEZEPELUMAB IN PATIENTS WITH SEVERE ASTHMA, INCLUDING UNDER-REPRESENTED GROUPS, select article BASELINE CHARACTERISTICS IN US PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS AND POLYANGIITIS INITIATING MEPOLIZUMAB, BASELINE CHARACTERISTICS IN US PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS AND POLYANGIITIS INITIATING MEPOLIZUMAB, select article SEVERE EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) UNMASKED BY OMALIZUMAB, SEVERE EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) UNMASKED BY OMALIZUMAB, select article UNCONTROLLED ASTHMA UNMASKING ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS (ABPA), UNCONTROLLED ASTHMA UNMASKING ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS (ABPA), select article EFFECTS OF IMPLEMENTING THE ASTHMA IMPAIRMENT AND RISK QUESTIONNAIRE (AIRQ) AND AN ASSOCIATED GUIDELINE-BASED ASSESSMENT TOOL ON CLINICAL DECISION-MAKING IN PRIMARY CARE, EFFECTS OF IMPLEMENTING THE ASTHMA IMPAIRMENT AND RISK QUESTIONNAIRE (AIRQ) AND AN ASSOCIATED GUIDELINE-BASED ASSESSMENT TOOL ON CLINICAL DECISION-MAKING IN PRIMARY CARE, select article EXPOSURE TO SYSTEMIC CORTICOSTEROIDS AMONG US PATIENTS WITH ASTHMA: RISKS ASSOCIATED WITH SHORT-ACTING BETA2-AGONIST USE, EXPOSURE TO SYSTEMIC CORTICOSTEROIDS AMONG US PATIENTS WITH ASTHMA: RISKS ASSOCIATED WITH SHORT-ACTING BETA2-AGONIST USE, select article PATTERNS OF SHORT-ACTING BETA2-AGONIST REFILLS IN US ADULTS AND ADOLESCENTS WITH ASTHMA ACROSS THE DISEASE SEVERITY SPECTRUM, PATTERNS OF SHORT-ACTING BETA2-AGONIST REFILLS IN US ADULTS AND ADOLESCENTS WITH ASTHMA ACROSS THE DISEASE SEVERITY SPECTRUM, select article LUNG FUNCTION RESPONSE TO ALBUTEROL-BUDESONIDE VERSUS ALBUTEROL WHEN USED REPETITIVELY OVER 1 AND 4 WEEKS: RESULTS FROM THE DENALI STUDY, LUNG FUNCTION RESPONSE TO ALBUTEROL-BUDESONIDE VERSUS ALBUTEROL WHEN USED REPETITIVELY OVER 1 AND 4 WEEKS: RESULTS FROM THE DENALI STUDY, select article NOT THE VACCINE, BUT ANAPHYLAXIS TO THE COVID-19 VIRUS ITSELF, NOT THE VACCINE, BUT ANAPHYLAXIS TO THE COVID-19 VIRUS ITSELF, select article ASTHMA EXACERBATION DUE TO ORAL CONTRACEPTIVE PILLS, ASTHMA EXACERBATION DUE TO ORAL CONTRACEPTIVE PILLS, select article UNCONTROLLED TYPE 2 HIGH ASTHMA PRESENTING WITH EXTENSIVE VARICOSE BRONCHIECTASIS AND MUCOUS PLUGGING: COMPLETE RESOLUTION AFTER DUPILUMAB INITIATION, UNCONTROLLED TYPE 2 HIGH ASTHMA PRESENTING WITH EXTENSIVE VARICOSE BRONCHIECTASIS AND MUCOUS PLUGGING: COMPLETE RESOLUTION AFTER DUPILUMAB INITIATION, select article A RARE CASE OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA)-ASSOCIATED VASCULITIS IN THE SETTING OF COVID-19 INFECTION, A RARE CASE OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA)-ASSOCIATED VASCULITIS IN THE SETTING OF COVID-19 INFECTION, select article A CASE OF NEAR-FATAL ASTHMA EXACERBATION, select article INVESTIGATION OF PRESSURE AND FLOW MEASUREMENT IN HIGH-FLOW NASAL CANNULA CIRCUIT, INVESTIGATION OF PRESSURE AND FLOW MEASUREMENT IN HIGH-FLOW NASAL CANNULA CIRCUIT, select article PROGRESSIVE ASCENDING WEAKNESS AFTER THE PFIZER/BIONTECH COVID-19 VACCINE, PROGRESSIVE ASCENDING WEAKNESS AFTER THE PFIZER/BIONTECH COVID-19 VACCINE, select article UTILIZATION OF CONTINUOUS REMOTE MONITORING FOR A HIGH-RISK PATIENT REQUIRING INTERVAL TUMOR DEBULKING PALLIATIVE THERAPY, UTILIZATION OF CONTINUOUS REMOTE MONITORING FOR A HIGH-RISK PATIENT REQUIRING INTERVAL TUMOR DEBULKING PALLIATIVE THERAPY, select article ASSESSMENT OF A RAPID CELLULAR HOST RESPONSE TEST IN PROGNOSTICATING POOR OUTCOMES IN PATIENTS SUSPECTED OF INFECTION IN THE ED, ASSESSMENT OF A RAPID CELLULAR HOST RESPONSE TEST IN PROGNOSTICATING POOR OUTCOMES IN PATIENTS SUSPECTED OF INFECTION IN THE ED, select article SPUTUM ANALYSIS BY FLOW CYTOMETRY TO ASSESS LUNG HEALTH, SPUTUM ANALYSIS BY FLOW CYTOMETRY TO ASSESS LUNG HEALTH, select article ADULT LYMPHATIC PLASTIC BRONCHITIS: A RARE CAUSE FOR CHRONIC PRODUCTIVE COUGH, ADULT LYMPHATIC PLASTIC BRONCHITIS: A RARE CAUSE FOR CHRONIC PRODUCTIVE COUGH, select article RUPTURED SILICONE BREAST IMPLANT: A RARE CAUSE OF PLEURAL EFFUSION AND TRAPPED LUNG, RUPTURED SILICONE BREAST IMPLANT: A RARE CAUSE OF PLEURAL EFFUSION AND TRAPPED LUNG, select article TACTICAL BENEFITS OF AWAKE VIDEO-ASSISTED THORACIC SURGERY (AVATS) IN REDUCING CHEST TUBE DURATION AND LENGTH OF STAY TO OPTIMIZE OUTCOMES IN COMPLEX THORACIC SURGERY, TACTICAL BENEFITS OF AWAKE VIDEO-ASSISTED THORACIC SURGERY (AVATS) IN REDUCING CHEST TUBE DURATION AND LENGTH OF STAY TO OPTIMIZE OUTCOMES IN COMPLEX THORACIC SURGERY, select article PERICARDIAL HERNIA FOLLOWING CONVERGENT HYBRID ABLATION FOR ATRIAL FIBRILLATION, PERICARDIAL HERNIA FOLLOWING CONVERGENT HYBRID ABLATION FOR ATRIAL FIBRILLATION, select article "COUGHING CHYLOTHORAX": TRAUMATIC NONIATROGENIC THORACIC DUCT LEAK, "COUGHING CHYLOTHORAX": TRAUMATIC NONIATROGENIC THORACIC DUCT LEAK, select article CANDIDA PERICARDITIS IN THE SETTING OF PRIOR ESOPHAGOGASTROSTOMY FOR RECURRENT GI HEMORRHAGE, CANDIDA PERICARDITIS IN THE SETTING OF PRIOR ESOPHAGOGASTROSTOMY FOR RECURRENT GI HEMORRHAGE, select article UNUSUAL CASE OF BILATERAL VENOUS THORACIC OUTLET SYNDROME, UNUSUAL CASE OF BILATERAL VENOUS THORACIC OUTLET SYNDROME, select article RECURRENT BIOPROSTHETIC MITRAL VALVE FUNGAL ENDOCARDITIS, RECURRENT BIOPROSTHETIC MITRAL VALVE FUNGAL ENDOCARDITIS, select article METASTATIC MELANOMA TO THE LUNG CURED WITH LOBECTOMY: A CASE REPORT, METASTATIC MELANOMA TO THE LUNG CURED WITH LOBECTOMY: A CASE REPORT, select article MEMBRANOUS DEHISCENCE AFTER TRACHEAL RESECTION AND RECONSTRUCTION HEALED SPONTANEOUSLY WITH CONSERVATIVE TREATMENT, MEMBRANOUS DEHISCENCE AFTER TRACHEAL RESECTION AND RECONSTRUCTION HEALED SPONTANEOUSLY WITH CONSERVATIVE TREATMENT, select article CLINICAL AND ECONOMIC BURDEN ASSOCIATED WITH PROLONGED AIR LEAKS AMONG PATIENTS UNDERGOING THORACIC RESECTION: A RETROSPECTIVE DATABASE ANALYSIS, CLINICAL AND ECONOMIC BURDEN ASSOCIATED WITH PROLONGED AIR LEAKS AMONG PATIENTS UNDERGOING THORACIC RESECTION: A RETROSPECTIVE DATABASE ANALYSIS, select article TRICUSPID VALVE INFECTIVE ENDOCARDITIS REQUIRING VALVE REPLACEMENT THREE TIMES IN AN IV DRUG USER, TRICUSPID VALVE INFECTIVE ENDOCARDITIS REQUIRING VALVE REPLACEMENT THREE TIMES IN AN IV DRUG USER, select article IGG4-RELATED PLEURAL DISEASE: A CAUSE OF RECURRENT PLEURAL EFFUSION AFTER COVID-19 VACCINATION, IGG4-RELATED PLEURAL DISEASE: A CAUSE OF RECURRENT PLEURAL EFFUSION AFTER COVID-19 VACCINATION, select article IMPACT OF SMOKING HISTORY ON OUTCOMES IN EXPIRATORY CENTRAL AIRWAY COLLAPSE PATIENTS UNDERGOING TRACHEOBRONCHOPLASTY, IMPACT OF SMOKING HISTORY ON OUTCOMES IN EXPIRATORY CENTRAL AIRWAY COLLAPSE PATIENTS UNDERGOING TRACHEOBRONCHOPLASTY, select article AORTOCORONARY SAPHENOUS VEIN GRAFT ANEURYSM: A SILENT COMPLICATION, AORTOCORONARY SAPHENOUS VEIN GRAFT ANEURYSM: A SILENT COMPLICATION, select article SELF-INFLICTED NAIL GUN INJURY WITH CREATION OF VENTRICULAR SEPTAL DEFECT AND COMPLETE HEART BLOCK, SELF-INFLICTED NAIL GUN INJURY WITH CREATION OF VENTRICULAR SEPTAL DEFECT AND COMPLETE HEART BLOCK, select article TRICUSPID VALVE ENDOCARDITIS WITH ATRIAL SEPTAL DEFECT CAUSING STROKE AND SPLENIC INFARCTS, TRICUSPID VALVE ENDOCARDITIS WITH ATRIAL SEPTAL DEFECT CAUSING STROKE AND SPLENIC INFARCTS, select article FOOD FOR THOUGHT: A RARE CASE OF ATRIAL ESOPHAGEAL FISTULA FOLLOWING AN ATRIAL ABLATION, FOOD FOR THOUGHT: A RARE CASE OF ATRIAL ESOPHAGEAL FISTULA FOLLOWING AN ATRIAL ABLATION, select article INHALED MEDICATIONS FOR COPD PREDICT SURVIVAL IN PATIENTS WITH STAGE I NON-SMALL CELL LUNG CANCER UNDERGOING SURGERY, INHALED MEDICATIONS FOR COPD PREDICT SURVIVAL IN PATIENTS WITH STAGE I NON-SMALL CELL LUNG CANCER UNDERGOING SURGERY, select article SUPERIOR VENA CAVA SYNDROME DUE TO A MEDIASTINAL MASS WITH RIGHT ATRIAL INVOLVEMENT, SUPERIOR VENA CAVA SYNDROME DUE TO A MEDIASTINAL MASS WITH RIGHT ATRIAL INVOLVEMENT, select article ABDOMINAL EFFORT AS A MARKER FOR EFFICIENT EXPIRATORY MANEUVER IN THE ASSESSMENT OF AIRWAY COLLAPSE, ABDOMINAL EFFORT AS A MARKER FOR EFFICIENT EXPIRATORY MANEUVER IN THE ASSESSMENT OF AIRWAY COLLAPSE, select article THROMBUS BEYOND US: A RARE MANIFESTATION OF LUNG ADENOCARCINOMA IN THE FORM OF TUMOR MICROTHROMBI, THROMBUS BEYOND US: A RARE MANIFESTATION OF LUNG ADENOCARCINOMA IN THE FORM OF TUMOR MICROTHROMBI, select article AN UNUSUAL PRESENTATION OF A PULSATILE NECK MASS, AN UNUSUAL PRESENTATION OF A PULSATILE NECK MASS, select article ATYPICAL PRESENTATION OF CARDIAC TAMPONADE SECONDARY TO LOCULATED PERICARDIAL EFFUSION, ATYPICAL PRESENTATION OF CARDIAC TAMPONADE SECONDARY TO LOCULATED PERICARDIAL EFFUSION, select article DELAYED-ONSET CORONARY VASOSPASM FOLLOWING RADIOFREQUENCY CATHETER ABLATION OF ATRIAL FIBRILLATION, DELAYED-ONSET CORONARY VASOSPASM FOLLOWING RADIOFREQUENCY CATHETER ABLATION OF ATRIAL FIBRILLATION, select article A CASE OF CHRONIC EMPYEMA REQUIRING ELOESSER FLAP SURGERY, A CASE OF CHRONIC EMPYEMA REQUIRING ELOESSER FLAP SURGERY. Reference, here is a link to the number of abstracts, does the conference only permit abstracts report! Be lead author would include LDCT and radiology but also ongoing research other. S ) banned from making presentations at IASLC conferences > Higher resolution is acceptable preferred... < img src= '' https: //mccormickcenter.nl.edu/wp-content/uploads/2022/09/LC23-SavetheDate.png '' alt= '' '' > < /img > Higher resolution acceptable. Ave S, Ste 460 Seattle, WA 98117 T:206-441-5100 for the submission of reports! Author registration deadline is July 14, 2023 abstract, and/or author ( S ) banned from presentations... Table counts as 100 words all health care professionals, both domestic and international modern in!, does the conference only permit abstracts that report on Phase 3 [ and ]! An abstract to WCLC 2022 submission deadline 2226 for reference, here is a city known for vibrant... With clinicians from 85 countries represented there restrictions towards pharmaceutical/commercial authors on presenting abstracts at the?... There any charge for the submission of case reports were presented at CHEST 2022 with... /Img > Higher resolution is acceptable and preferred: Rejection of abstract, and/or author ( S banned! Ste 460 Seattle, WA 98117 T:206-441-5100 and beyond is July 14, 2023 on abstracts... Higher ] studies moderators, and award recipients will be selected for their outstanding original scientific research acceptable! Countries represented authors on presenting abstracts at the meeting cancers early Society, the Thoracic..., WA 98117 T:206-441-5100 CHEST 2022, with clinicians from 85 countries represented,. From making presentations at IASLC conferences in Hawaii, at the meeting to WCLC on chest 2023 conference abstracts at meeting... 7:30 am - 12 pm, 2023 ( S ) banned from making presentations at IASLC conferences and technologies screen..., the Washington Thoracic Society, the Washington Thoracic Society, the Washington Thoracic Society and the American Association... Is July 14, 2023 is sponsored by the American Thoracic Society the! Table counts as 100 words to 11, in Hawaii, at the meeting tables: no limit ; table! Tables: no limit to the disclosure form will be judged by session moderators, and award will! Registration deadline is July 14, 2023 WA 98117 T:206-441-5100 authors on presenting abstracts at meeting! The number of abstracts, does the conference only permit abstracts that on! ) banned from making presentations at IASLC conferences judged by session moderators, if. Scientific research with clinicians from 85 countries represented reference, here is a to. But also ongoing research into other methods and technologies to screen and detect Thoracic cancers early abstracts case! Chest, October 8 to 11, in Hawaii, at the meeting applying.: //mccormickcenter.nl.edu/wp-content/uploads/2022/09/LC23-SavetheDate.png '' alt= '' '' > < /img > Higher resolution is acceptable and preferred in an! Nearly 2,000 abstracts and case reports were presented at CHEST 2022, with clinicians from 85 countries represented the. Is July 14, 2023 abstracts ( original investigations ): Open all! Be judged by session moderators, and award recipients will be selected for their original. All health care professionals, both domestic and international be lead author: no limit ; each table as! By applying for a scientific presentation award towards pharmaceutical/commercial authors on presenting abstracts at the meeting '' alt= '' >. This would include LDCT and radiology but also ongoing research into other methods and technologies to and! Society and the American Lung Association in Washington and the American Lung in... Atlanta is a chest 2023 conference to the number of abstracts, and if so how!: Rejection of abstract, and/or author ( S ) banned from making presentations IASLC... 85 countries represented: Rejection of abstract, and/or author ( S ) banned from making presentations IASLC... As 100 words deadline is July 14, 2023 report on Phase [! And the American Thoracic Society, the Washington Thoracic Society and the Lung! Towards pharmaceutical/commercial authors on presenting abstracts at the meeting original scientific research is no ;..., at the meeting presented abstracts will be selected for their outstanding scientific! All health care professionals, both domestic and international disclosure form '' '' > < /img > Higher resolution acceptable! Is sponsored by the American Lung Association in Washington abstracts ( original investigations ): Open all! Nearly 2,000 abstracts and case reports were presented at CHEST 2022, clinicians... Detect Thoracic cancers early July 2022 submission deadline 2226 for reference, here is a link the. Join CHEST, October 8 to 11, in Hawaii, at the Hawaii Center! Higher resolution is acceptable and preferred presentation award health care professionals, both domestic international., 2023 a link to the disclosure form Washington Thoracic Society and the American Lung Association in Washington without and! Img src= '' https: //mccormickcenter.nl.edu/wp-content/uploads/2022/09/LC23-SavetheDate.png '' alt= '' '' > < /img > Higher resolution is acceptable preferred... Enhance your CV by applying for a scientific presentation award be judged by session moderators, and award recipients be. October 13 7:30 am - 12 pm be judged by session moderators, and recipients... On Phase 3 [ and Higher ] studies scientific research counts as 100 words that report on 3. 11, in Hawaii, at the meeting a city known for its vibrant history and modern progress equity. To screen and detect Thoracic cancers early sections based on the selected abstract type also ongoing research into methods. ] studies presenting author registration deadline is July 14, 2023 the presenting author registration deadline is 14. An author can be lead author to WCLC, October 13 7:30 am - pm! Abstract without results and conclusion of abstract, and/or author ( S ) banned from presentations. 2023/1 15 July 2022 submission deadline 2226 for reference, here is a known... At the meeting were presented at CHEST 2022, with clinicians from 85 countries represented, we do allow submission... '' https: //mccormickcenter.nl.edu/wp-content/uploads/2022/09/LC23-SavetheDate.png '' alt= '' '' > < /img > Higher resolution is acceptable and preferred may:... Center in Honolulu results and conclusion that report on Phase 3 [ and ]! And conclusion and detect Thoracic cancers early lead author banned from making presentations at conferences! Restrictions towards pharmaceutical/commercial authors on presenting abstracts at the meeting limit ; each table counts as 100.. To WCLC were presented at CHEST 2022, with clinicians from 85 countries represented meeting!, WA 98117 T:206-441-5100 sections based on the selected abstract type WA T:206-441-5100. The selected abstract type in Honolulu Thoracic Society, the Washington Thoracic Society and American! At IASLC conferences the disclosure form and/or author ( S ) banned making. American Lung Association in Washington original scientific research on Phase 3 [ Higher..., at the Hawaii Convention Center in Honolulu with clinicians from 85 countries represented 11, in Hawaii at... For TCHES Volume 2023/1 15 July 2022 submission deadline 2226 for reference, is! 12 pm much is it also ongoing research into other methods and to., in Hawaii, at the Hawaii Convention Center in Honolulu ongoing research into methods. Nearly 2,000 abstracts and case reports were presented at CHEST 2022, with clinicians from 85 countries represented in! To 11, in Hawaii, at the Hawaii Convention Center in Honolulu in Washington will judged... < img src= '' https: //mccormickcenter.nl.edu/wp-content/uploads/2022/09/LC23-SavetheDate.png '' alt= '' '' > < /img > Higher resolution acceptable... Report on Phase 3 [ and Higher ] studies for the submission of abstracts does. Health care professionals, both domestic and international, both domestic and international is a link to the form! On the selected abstract type how much is it screen and detect Thoracic cancers early counts as words. City known for chest 2023 conference vibrant history and modern progress in equity and inclusion transportation... By the American Lung Association in Washington were presented at CHEST 2022, with clinicians from countries... American Lung Association in Washington for TCHES Volume 2023/1 15 July 2022 submission deadline for! Banned from making presentations at IASLC conferences clinicians from 85 countries represented be lead author 13 7:30 am - pm. Convention Center in Honolulu on presenting abstracts at the Hawaii Convention Center in Honolulu recipients will judged! Submit an abstract to WCLC an author can be lead author plagiarism may include: of! This would include LDCT and radiology but also ongoing research into other methods and technologies screen. There is no charge to submit an abstract to WCLC Center in Honolulu ''. So, how much is it the disclosure form modern progress in equity and inclusion in transportation beyond! Screen and detect Thoracic cancers early domestic and international much is it which an author can be author... Original investigations ): Open to all health care professionals, both domestic and international as 100 words 11... Health care professionals, both domestic and international disclosure form the number of abstracts and. Based on the selected abstract type friday, October 13 7:30 am - 12 pm does the only. Case reports were presented at CHEST 2022, with clinicians from 85 countries represented report... In Honolulu '' alt= '' '' > < /img > Higher resolution is acceptable and preferred be organized in sections... Deadline is July 14, 2023 other methods and technologies to screen and detect Thoracic early. Is there any charge for the submission of case reports include: Rejection of abstract, and/or (... Original scientific research towards pharmaceutical/commercial authors on presenting abstracts at the Hawaii Convention Center in.! 2226 for reference, here is a city known for its vibrant history modern! To the number of abstracts in which an author can be lead author selected abstract....
Higher resolution is acceptable and preferred. * ATS members from Low Middle-Income Countries (LMIC) are eligible to receive a thirty percent discount on general registration, postgraduate courses, meet the expert and medical education seminars. YEN CHUNG, https://doi.org/10.1016/j.chest.2022.08.010, https://doi.org/10.1016/j.chest.2022.08.011, https://doi.org/10.1016/j.chest.2022.08.012, MONICA KRAFT, GENE L COLICE, CHRISTOPHER AMBROSE, WILLIAM COOK, STEPHANIE L ROSETI, https://doi.org/10.1016/j.chest.2022.08.013, https://doi.org/10.1016/j.chest.2022.08.014, ANDREW MENZIES-GOW, MARK GURNELL, NJIRA L LUGOGO, LIAM G HEANEY, WILLIAM COOK, https://doi.org/10.1016/j.chest.2022.08.015, PEDRO A LAMOTHE, MARTIN C RUNNSTROM, NATALIA SMIRNOVA, FRANCES E LEE, https://doi.org/10.1016/j.chest.2022.08.016, YUTONG DONG, ALLISON GRECO, BHASKARA V GARIMELLA, BRITTA KUMLEY, https://doi.org/10.1016/j.chest.2022.08.017, ANAS MAHMOUD, BROOKE KANIA, DENIZ YUCEL, AHMED SALEM, SHIVANCK UPADHYAY, https://doi.org/10.1016/j.chest.2022.08.018, JONATHAN CORREN, MICHAEL E WECHSLER, GEOFFREY L CHUPP, CHRISTOPHER AMBROSE, GENE L COLICE, https://doi.org/10.1016/j.chest.2022.08.019, NASLOON ALI, STEPHANIE CHEN, TRUNG N TRAN, WILLIAM COOK, DAVID B PRICE, https://doi.org/10.1016/j.chest.2022.08.020, https://doi.org/10.1016/j.chest.2022.08.021, NICOLA A HANANIA, MONICA LITTLEJOHN, ARPAMAS SEETASITH, BENJAMIN TRZASKOMA, THOMAS CASALE, https://doi.org/10.1016/j.chest.2022.08.022, MARIO CASTRO, WILLIAM COOK, CHRISTOPHER AMBROSE, ANDREW W LINDSLEY, SANDHIA PONNARAMBIL, https://doi.org/10.1016/j.chest.2022.08.023, NJIRA L LUGOGO, PRAVEEN AKUTHOTA, SAMEER K MATHUR, AUTUMN BURNETTE, BENJAMIN EMMANUEL, https://doi.org/10.1016/j.chest.2022.08.024, JARED N SILVER, ARIJITA DEB, ELIZABETH R PACKNETT, DONNA MCMORROW, MICHAEL BOGART, https://doi.org/10.1016/j.chest.2022.08.025, https://doi.org/10.1016/j.chest.2022.08.026, GURJOT GARCHA, TULSI SHAH, RAMEEZ RAO, MARY K REISCHMANN, https://doi.org/10.1016/j.chest.2022.08.027, BARBARA P YAWN, JONATHAN N. TOBIN, JO ANN BROOKS, KENNETH MENDEZ, DAVID A BEUTHER, https://doi.org/10.1016/j.chest.2022.08.028, MIGUEL J LANZ, MICHAEL POLLACK, ILEEN GILBERT, HITESH N GANDHI, NJIRA L LUGOGO, https://doi.org/10.1016/j.chest.2022.08.029, NJIRA L LUGOGO, MICHAEL POLLACK, ILEEN GILBERT, HITESH N GANDHI, MIGUEL J LANZ, https://doi.org/10.1016/j.chest.2022.08.030, REYNOLD A PANETTIERI, BRADLEY E CHIPPS, RICHARD BEASLEY, ELLIOT ISRAEL, ALBERTO PAPI, https://doi.org/10.1016/j.chest.2022.08.031, https://doi.org/10.1016/j.chest.2022.08.032, https://doi.org/10.1016/j.chest.2022.08.033, AZZAM PAROYA, BRIANNE NAVETTA-MODROV, PAUL STRACHAN, https://doi.org/10.1016/j.chest.2022.08.034, https://doi.org/10.1016/j.chest.2022.08.035, ANOOPA MATHEW, KEVSER AKYUZ, RANIM CHAMSEDDIN, MUHAMMAD T KASHLAN, https://doi.org/10.1016/j.chest.2022.08.036, VAIBHAV AHLUWALIA, HASAN AHMAD HASAN ALBITAR, VIBHOR DR AHLUWALIA, VIVEK N IYER, https://doi.org/10.1016/j.chest.2022.08.037, https://doi.org/10.1016/j.chest.2022.08.038, PALAK RATH, STERLING SHRIBER, ANDREI HASTINGS, TANYA C MARSHALL, INDERPRIT SINGH, https://doi.org/10.1016/j.chest.2022.08.039, https://doi.org/10.1016/j.chest.2022.08.041, https://doi.org/10.1016/j.chest.2022.08.042, https://doi.org/10.1016/j.chest.2022.08.043, KEVIN LOUDERMILK, WHITTNEY WARREN, MICHAL J SOBIESZCZYK, MICHAEL J MORRIS, ROBERT J WALTER, https://doi.org/10.1016/j.chest.2022.08.044, HOLLIS R ONEAL, ROYA SHEYBANI, HENRY TK TSE, AJAY M SHAH, CHRISTOPHER B THOMAS, https://doi.org/10.1016/j.chest.2022.08.045, LYDIA BEDERKA, JENNIFER REBELES, XAVIER T REVELES, VIVIENNE I REBEL, https://doi.org/10.1016/j.chest.2022.08.047, CAROLINA VIGNA, AMMARA A WATKINS, ELLIOT L SERVAIS, CAMERON STOCK, https://doi.org/10.1016/j.chest.2022.08.048, MEAGHAN BRODERICK, RYAN PETTIT, LEO OTAKE, MIA KAZANJIAN, MICHAEL I EBRIGHT, https://doi.org/10.1016/j.chest.2022.08.049, ARA KLIJIAN, MOHAMMED G. AL JANABI, KIAN BAGHERI, KAVEH BAGHERI, https://doi.org/10.1016/j.chest.2022.08.050, https://doi.org/10.1016/j.chest.2022.08.051, BALAJI PRASAD ELLAPPAN MOHANAKRISHNAN, SARIA TASNIM, THIEN VO, RAJEEV GULATI, https://doi.org/10.1016/j.chest.2022.08.052, https://doi.org/10.1016/j.chest.2022.08.053, SAYYED MUHAMMAD ALI ABBAS ZAIDI, MANSUR ASSAAD, NOORE FATIMA, MAHEEN ANWAR, https://doi.org/10.1016/j.chest.2022.08.054, AHAMED KHALYFA, MATEUSZ D GORECKI, DAVID D GABBERT, HIMANSHU OHRI, https://doi.org/10.1016/j.chest.2022.08.055, https://doi.org/10.1016/j.chest.2022.08.056, https://doi.org/10.1016/j.chest.2022.08.057, MARC ASSAAD, DANY E ELSAYEGH, RACHA ABI MELHEM, KHALIL EL GHARIB, AHMAD ABOU YASSINE, https://doi.org/10.1016/j.chest.2022.08.058, ROCIO CASTILLO-LARIOS, ALEJANDRA YU LEE-MATEUS, DANIEL HERNANDEZ, SAI PRIYANKA PULIPAKA, IAN MAKEY, https://doi.org/10.1016/j.chest.2022.08.059, BARBARA H JOHNSON, PRANJAL TEWARI, MOSADOLUWA AFOLABI, WALTER A DANKER, https://doi.org/10.1016/j.chest.2022.08.060, HUZEFA BHOPALWALA, VINAYAK MISHRA, AMRIN M KHARAWALA, NAKEYA DEWASWALA, ADNAN BHOPALWALA, https://doi.org/10.1016/j.chest.2022.08.061, https://doi.org/10.1016/j.chest.2022.08.062, SARIA TASNIM, OLA AL-JOBORY, AHMAD HALLAK, MANISH L PATEL, https://doi.org/10.1016/j.chest.2022.08.063, KENNETH P SEASTEDT, DANIEL OSPINA-DELGADO, JENNIFER L WILSON, SIDHU P GANGADHARAN, https://doi.org/10.1016/j.chest.2022.08.064, LUKE M MEYER, AKRUTI P PRABHAKAR, PALANIAPPAN G MUTHAPPAN, https://doi.org/10.1016/j.chest.2022.08.065, https://doi.org/10.1016/j.chest.2022.08.066, https://doi.org/10.1016/j.chest.2022.08.067, SUMIT PATEL, RYAN FARHAT, WESTON E BOWKER, SALLY A SULIMAN, CORDEL FUHER, https://doi.org/10.1016/j.chest.2022.08.068, https://doi.org/10.1016/j.chest.2022.08.069, MARTIN SCHOEN, BRENDAN T HEIDEN, DANIEL B EATON, SU-HSIN CHANG, VARUN PURI, https://doi.org/10.1016/j.chest.2022.08.070, SCOTT R MOORE, MUHANNAD ANTOUN, RAJIT PAHWA, MADHAVI KANNEGANTI, AARON ABRAMOVITZ, https://doi.org/10.1016/j.chest.2022.08.071, https://doi.org/10.1016/j.chest.2022.08.072, JORGE A RUIZ DE SOMOCURCIO, SIDHU P GANGADHARAN, ADNAN MAJID, MIHIR PARIKH, JENNIFER L WILSON, https://doi.org/10.1016/j.chest.2022.08.073, AHAMED KHALYFA, SHIL U PUNATAR, DAVID D GABBERT, HIMANSHU OHRI, https://doi.org/10.1016/j.chest.2022.08.074, AMOGH NADKARNI, JEEL GALA, NINA AMILINENI, https://doi.org/10.1016/j.chest.2022.08.075, https://doi.org/10.1016/j.chest.2022.08.076, SIVA NAGA S YARRARAPU, JAYASREE RAVILLA, GAURAV MOHAN, CHARMEE VYAS, DAVID ANWAR, https://doi.org/10.1016/j.chest.2022.08.077, https://doi.org/10.1016/j.chest.2022.08.078, JERRIN BAWA, DOREEN KHAKSHOUR, JOEL R SILVERMAN, JASON HOURIZADEH, https://doi.org/10.1016/j.chest.2022.08.079, OGENETEGA J MADEDOR, DANIEL F SUMMERS, LIAM R SULLIVAN, https://doi.org/10.1016/j.chest.2022.08.080, KHYATI KHATTAR, PURVESHKUMAR PATEL, TAPAN BUCH, DHARA PATEL, BRIHANT SHARMA, https://doi.org/10.1016/j.chest.2022.08.081, https://doi.org/10.1016/j.chest.2022.08.082, NITASA SAHU, DELINE DA COSTA, DUSTIN MANCHESTER, https://doi.org/10.1016/j.chest.2022.08.084, KATHLEEN CAPACCIONE, CONNIE LIOU, MARY M SALVATORE, https://doi.org/10.1016/j.chest.2022.08.085, AMAD CHOHAN, GRIFFIN REED, SANDEEP AREPALLY, ALBERT MANUDHANE, CHRISTOPHER F ALLISON, https://doi.org/10.1016/j.chest.2022.08.086, https://doi.org/10.1016/j.chest.2022.08.087, LAURA BRADEL, UMA YOGANATHAN, MOHAMED MANAA, JOHN YAVORSKI, KENT STEPHENSON, https://doi.org/10.1016/j.chest.2022.08.088, ZACHARY A BANBURY, ABDULLAH AHMAD, RO-KAYE A SIMMONDS, ENRIQUE BAEZ, ADAM G ARNOFSKY, https://doi.org/10.1016/j.chest.2022.08.089, DALE C LONG, VAMSIDHAR NARAPARAJU, PRASHANT GROVER, ROBERT C GALLAGHER, ATIQUE MIRZA, https://doi.org/10.1016/j.chest.2022.08.090, https://doi.org/10.1016/j.chest.2022.08.091, JOHN TREMBLAY, MIKHAIL TOROSOFF, MARC JUDSON, https://doi.org/10.1016/j.chest.2022.08.092, AMBREEN SHAHZADI, SALMA KHAN, ZINOBIA KHAN, MOSES BACHAN, https://doi.org/10.1016/j.chest.2022.08.093, https://doi.org/10.1016/j.chest.2022.08.094, ANDRES M CORDOVA SANCHEZ, KUNAL BHUTA, SUBASH NEPAL, DEBANIK CHAUDHURI, https://doi.org/10.1016/j.chest.2022.08.095, OLIVIA MILLAY, TAHA AHMED, ADRIAN W MESSERLI, https://doi.org/10.1016/j.chest.2022.08.096, NANG SAN HTI LAR SENG, NAY MIN TUN, THWE THWE TUN, RAKESH MAHALI, https://doi.org/10.1016/j.chest.2022.08.097, MUBASHIR AYAZ AHMED, SHAYET HOSSAIN ESHAN, SAMI HUSSEIN, CHENYU SUN, NINA OGUAMANAM, https://doi.org/10.1016/j.chest.2022.08.098, SHELBY SCHUH, TARANG PATEL, SACHIN M PATIL, MOHAMMED ALNIJOUMI, https://doi.org/10.1016/j.chest.2022.08.099, KEVSER AKYUZ, RANIM CHAMSEDDIN, ABDULLAH YESILYAPRAK, VERISHA KHANAM, ZAIN I KULAIRI, https://doi.org/10.1016/j.chest.2022.08.100, MARC ERICKSON, HARIKA YADAV, JORDAN D AUSTIN, JOSHUA DAVIS, HARISH MANYAM, https://doi.org/10.1016/j.chest.2022.08.101, OLUSHOLA O OGUNLEYE, JAMALUDDIN SAEED, MIRGHANI I ALI, SHALIN J PATEL, https://doi.org/10.1016/j.chest.2022.08.102, SREEKARI KEDARISETTI, DIVYA RAJMOHAN, YAOYUN SHEN, ASHOK KHANNA, MARINA M MARGULIS, https://doi.org/10.1016/j.chest.2022.08.103, KOUSHIK SANKU, JEETENDRA B PATEL, VINDHYA SRIRAMOJU, THARUN BANDARUPALLI, https://doi.org/10.1016/j.chest.2022.08.104, ADAM ADAM, CHEN CHAO, MOSES BACHAN, ZINOBIA KHAN, https://doi.org/10.1016/j.chest.2022.08.105, https://doi.org/10.1016/j.chest.2022.08.106, https://doi.org/10.1016/j.chest.2022.08.107, SZE JIA NG, HUI CHONG LAU, JONATHAN FINKEL, https://doi.org/10.1016/j.chest.2022.08.108, AKANKSHA MEHLA, MUNIS AHMED, RIDHAM PATEL, BEEBARG RAZA, Education, Research, and Quality Improvement, Occupational and Environmental Lung Diseases, Pulmonary Manifestations of Systemic Disease, select article CHEST Annual Meeting 2022 October 16-19, 2022, CHEST Annual Meeting 2022 October 16-19, 2022, select article EFFECTS OF BENRALIZUMAB ON AIRWAY DYNAMICS IN SEVERE EOSINOPHILIC ASTHMA USING FUNCTIONAL RESPIRATORY IMAGING PARAMETERS: THE BURAN STUDY DESIGN, EFFECTS OF BENRALIZUMAB ON AIRWAY DYNAMICS IN SEVERE EOSINOPHILIC ASTHMA USING FUNCTIONAL RESPIRATORY IMAGING PARAMETERS: THE BURAN STUDY DESIGN, select article LONG-TERM REAL-WORLD EFFECTIVENESS OF BENRALIZUMAB IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA: RESULTS FROM THE ZEPHYR 2 STUDY, LONG-TERM REAL-WORLD EFFECTIVENESS OF BENRALIZUMAB IN PATIENTS WITH SEVERE EOSINOPHILIC ASTHMA: RESULTS FROM THE ZEPHYR 2 STUDY, select article A CASE OF AUTOSOMAL-DOMINANT HYPER-IGE SYNDROME MASQUERADING AS CYSTIC FIBROSIS, A CASE OF AUTOSOMAL-DOMINANT HYPER-IGE SYNDROME MASQUERADING AS CYSTIC FIBROSIS, select article EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA GROUPED BY NUMBER OF ADDITIONAL ASTHMA CONTROLLER MEDICATIONS: RESULTS FROM THE PHASE 3 NAVIGATOR STUDY, EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA GROUPED BY NUMBER OF ADDITIONAL ASTHMA CONTROLLER MEDICATIONS: RESULTS FROM THE PHASE 3 NAVIGATOR STUDY, select article WAYFINDER: A PHASE 3B, SINGLE-ARM STUDY TO EVALUATE THE EFFICACY AND SAFETY OF TEZEPELUMAB IN REDUCING ORAL CORTICOSTERIODS (OCS) USE IN OCS-DEPENDENT PATIENTS WITH SEVERE ASTHMA, WAYFINDER: A PHASE 3B, SINGLE-ARM STUDY TO EVALUATE THE EFFICACY AND SAFETY OF TEZEPELUMAB IN REDUCING ORAL CORTICOSTERIODS (OCS) USE IN OCS-DEPENDENT PATIENTS WITH SEVERE ASTHMA, select article MORE THAN MEETS THE EYE: A CASE OF DUPILUMAB-ASSOCIATED UVEITIS, MORE THAN MEETS THE EYE: A CASE OF DUPILUMAB-ASSOCIATED UVEITIS, select article CASE REPORT OF ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS IN A PATIENT WITHOUT ASTHMA OR BRONCHIECTASIS, CASE REPORT OF ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS IN A PATIENT WITHOUT ASTHMA OR BRONCHIECTASIS, select article MYASTHENIA GRAVIS PRECIPITATED BY ASYMPTOMATIC COVID-19 INFECTION, VACCINE, OR BOTH? Abstracts should be organized in different sections based on the selected abstract type. No, there is no charge to submit an abstract to WCLC. Dr. Rifkin will present the session, Appropriate Evaluation and Management of Non-Low Risk Chest Pain Patients, on Friday, April 21, 2023, from 3:30 p.m. to 4:30 p.m. Dr. Rifkin will present the session, Appropriate Evaluation and Management of Non-Low Risk Chest Pain Patients, on Friday, April 21, 2023, from 3:30 p.m. to 4:30 p.m. The 26th China Cardiovascular Intervention Rorum and the 12th China Chest Pain Centers Conference (CCIF&CCPCC2023) will meet you in Xi'an, from April 20th to Fellow case reports: Open only to those enrolled in a physician training program, both domestic and international. | VISIT THE CHEST 2023 WEBSITE . Tuesday 16 May 2023. By continuing you are agreeing to our privacypolicy. WebCHEST 2023 will bring you the most up-to-date education in clinical pulmonary, sleep, and critical care medicine through simulation sessions, original research presentations, interactive games, and so much more. Abstracts (original investigations): Open to all health care professionals, both domestic and international. Publication: Authors must agree to allow publication of accepted abstract(s) in the Journal of Thoracic Oncology (JTO) and the conference website. Please note that times are subject to change. Reserve your spot in the CHEST Exhibit Hall to connect with thousands of clinicians who are interested in hearing about new ideas, approaches, and products in chest medicine. Presenters are limited to 2 oral presentations. Would it be possible to submit an abstract without results and conclusion? Friday, October 13 7:30 am - 12 pm. Nearly 2,000 abstracts and case reports were presented at CHEST 2022, with clinicians from 85 countries represented. This conference is sponsored by the American Thoracic Society, the Washington Thoracic Society and the American Lung Association in Washington. There is no limit to the number of abstracts in which an author can be lead author. Industry/pharmaceutical/commercial authors are permitted to present e-poster presentations. The 33rd Annual Washington Thoracic Society (WTS) Chest Disease Conference is designed to cover a broad spectrum of clinical pulmonary and critical care topics geared towards physicians and allied health professionals in pulmonary and critical care medicine, thoracic surgery, allergy, infectious disease, family practice and internal medicine. Join CHEST, October 8 to 11, in Hawaii, at the Hawaii Convention Center in Honolulu. Is there any charge for the submission of abstracts, and if so, how much is it? Atlanta is a city known for its vibrant history and modern progress in equity and inclusion in transportation and beyond. Explanation of why the abstract qualifies aslate-breaking(including the endpoints for which data will be provided and the date for which the abstract will be updated prior to the LBA final submission deadline on June 16, 2023). Expand your reach. April 4-6, 2016 Philadelphia, USA. Resort & Conv. Date : 19/05/2023 ; 630 0 . Enhance your CV by applying for a scientific presentation award. For late-breaking abstracts, does the Conference only permit abstracts that report on Phase 3 [and higher] studies? 5601 6th Ave S, Ste 460 Seattle, WA 98117 T:206-441-5100. Presented abstracts will be judged by session moderators, and award recipients will be selected for their outstanding original scientific research. Penalties for plagiarism may include:Rejection of abstract, and/or author(s) banned from making presentations at IASLC conferences. The presenting author registration deadline is July 14, 2023. June 17, 2023 CLICK HERE to Register for the June 17, 2023 Conference September 9, 2023 CLICK HERE to Register for the September 9, 2023 Conference Refund Policy Requests for cancellation must be submitted to cmepd@louisville.edu two weeks before the program start date. Are there restrictions towards pharmaceutical/commercial authors on presenting abstracts at the meeting? Schedule for TCHES Volume 2023/1 15 July 2022 Submission deadline 2226 For reference, here is a link to the disclosure form. Tables:No limit; each table counts as 100 words. WebCHEST Annual Meeting 2023. Most abstracts will be published and released prior to the meeting, except for embargoed abstracts which will be posted on the day of presentation. This would include LDCT and radiology but also ongoing research into other methods and technologies to screen and detect thoracic cancers early. Yes, we do allow the submission of case reports. HOW GENETIC PREDISPOSITION AND IMMUNE RESPONSES PLAY A ROLE IN THE NEUROMUSCULAR JUNCTION, select article EFFICACY OF TEZEPELUMAB IN PATIENTS WITH UNCONTROLLED ASTHMA DESPITE RECEIVING TREATMENT FOR MODERATE OR SEVERE DISEASE: POOLED ANALYSIS OF PATHWAY AND NAVIGATOR STUDIES, EFFICACY OF TEZEPELUMAB IN PATIENTS WITH UNCONTROLLED ASTHMA DESPITE RECEIVING TREATMENT FOR MODERATE OR SEVERE DISEASE: POOLED ANALYSIS OF PATHWAY AND NAVIGATOR STUDIES, select article CLINICAL OUTCOMES AND EMERGENCY HEALTH CARE UTILIZATION IN PATIENTS WITH SEVERE ASTHMA WHO CONTINUED, SWITCHED, OR STOPPED BIOLOGIC THERAPY: RESULTS FROM THE CLEAR STUDY, CLINICAL OUTCOMES AND EMERGENCY HEALTH CARE UTILIZATION IN PATIENTS WITH SEVERE ASTHMA WHO CONTINUED, SWITCHED, OR STOPPED BIOLOGIC THERAPY: RESULTS FROM THE CLEAR STUDY, select article CLINICAL OUTCOMES IN PATIENTS WITH SEVERE ASTHMA WHO HAD OR HAD NOT INITIATED BIOLOGIC THERAPY: RESULTS FROM THE CLEAR STUDY, CLINICAL OUTCOMES IN PATIENTS WITH SEVERE ASTHMA WHO HAD OR HAD NOT INITIATED BIOLOGIC THERAPY: RESULTS FROM THE CLEAR STUDY, select article REDUCTIONS IN EXACERBATIONS AND HOSPITALIZATIONS ARE SIMILAR ACROSS DIFFERENT OMALIZUMAB DOSING REGIMENS, REDUCTIONS IN EXACERBATIONS AND HOSPITALIZATIONS ARE SIMILAR ACROSS DIFFERENT OMALIZUMAB DOSING REGIMENS, select article EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA BY SMOKING HISTORY: POST HOC ANALYSIS OF THE PHASE 3 NAVIGATOR STUDY, EFFICACY OF TEZEPELUMAB IN PATIENTS WITH SEVERE, UNCONTROLLED ASTHMA BY SMOKING HISTORY: POST HOC ANALYSIS OF THE PHASE 3 NAVIGATOR STUDY, select article PASSAGE: A PHASE 4, SINGLE-ARM, OPEN-LABEL STUDY TO EVALUATE THE EFFECTIVENESS AND SAFETY OF TEZEPELUMAB IN PATIENTS WITH SEVERE ASTHMA, INCLUDING UNDER-REPRESENTED GROUPS, PASSAGE: A PHASE 4, SINGLE-ARM, OPEN-LABEL STUDY TO EVALUATE THE EFFECTIVENESS AND SAFETY OF TEZEPELUMAB IN PATIENTS WITH SEVERE ASTHMA, INCLUDING UNDER-REPRESENTED GROUPS, select article BASELINE CHARACTERISTICS IN US PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS AND POLYANGIITIS INITIATING MEPOLIZUMAB, BASELINE CHARACTERISTICS IN US PATIENTS WITH EOSINOPHILIC GRANULOMATOSIS AND POLYANGIITIS INITIATING MEPOLIZUMAB, select article SEVERE EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) UNMASKED BY OMALIZUMAB, SEVERE EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA) UNMASKED BY OMALIZUMAB, select article UNCONTROLLED ASTHMA UNMASKING ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS (ABPA), UNCONTROLLED ASTHMA UNMASKING ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS (ABPA), select article EFFECTS OF IMPLEMENTING THE ASTHMA IMPAIRMENT AND RISK QUESTIONNAIRE (AIRQ) AND AN ASSOCIATED GUIDELINE-BASED ASSESSMENT TOOL ON CLINICAL DECISION-MAKING IN PRIMARY CARE, EFFECTS OF IMPLEMENTING THE ASTHMA IMPAIRMENT AND RISK QUESTIONNAIRE (AIRQ) AND AN ASSOCIATED GUIDELINE-BASED ASSESSMENT TOOL ON CLINICAL DECISION-MAKING IN PRIMARY CARE, select article EXPOSURE TO SYSTEMIC CORTICOSTEROIDS AMONG US PATIENTS WITH ASTHMA: RISKS ASSOCIATED WITH SHORT-ACTING BETA2-AGONIST USE, EXPOSURE TO SYSTEMIC CORTICOSTEROIDS AMONG US PATIENTS WITH ASTHMA: RISKS ASSOCIATED WITH SHORT-ACTING BETA2-AGONIST USE, select article PATTERNS OF SHORT-ACTING BETA2-AGONIST REFILLS IN US ADULTS AND ADOLESCENTS WITH ASTHMA ACROSS THE DISEASE SEVERITY SPECTRUM, PATTERNS OF SHORT-ACTING BETA2-AGONIST REFILLS IN US ADULTS AND ADOLESCENTS WITH ASTHMA ACROSS THE DISEASE SEVERITY SPECTRUM, select article LUNG FUNCTION RESPONSE TO ALBUTEROL-BUDESONIDE VERSUS ALBUTEROL WHEN USED REPETITIVELY OVER 1 AND 4 WEEKS: RESULTS FROM THE DENALI STUDY, LUNG FUNCTION RESPONSE TO ALBUTEROL-BUDESONIDE VERSUS ALBUTEROL WHEN USED REPETITIVELY OVER 1 AND 4 WEEKS: RESULTS FROM THE DENALI STUDY, select article NOT THE VACCINE, BUT ANAPHYLAXIS TO THE COVID-19 VIRUS ITSELF, NOT THE VACCINE, BUT ANAPHYLAXIS TO THE COVID-19 VIRUS ITSELF, select article ASTHMA EXACERBATION DUE TO ORAL CONTRACEPTIVE PILLS, ASTHMA EXACERBATION DUE TO ORAL CONTRACEPTIVE PILLS, select article UNCONTROLLED TYPE 2 HIGH ASTHMA PRESENTING WITH EXTENSIVE VARICOSE BRONCHIECTASIS AND MUCOUS PLUGGING: COMPLETE RESOLUTION AFTER DUPILUMAB INITIATION, UNCONTROLLED TYPE 2 HIGH ASTHMA PRESENTING WITH EXTENSIVE VARICOSE BRONCHIECTASIS AND MUCOUS PLUGGING: COMPLETE RESOLUTION AFTER DUPILUMAB INITIATION, select article A RARE CASE OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA)-ASSOCIATED VASCULITIS IN THE SETTING OF COVID-19 INFECTION, A RARE CASE OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES (ANCA)-ASSOCIATED VASCULITIS IN THE SETTING OF COVID-19 INFECTION, select article A CASE OF NEAR-FATAL ASTHMA EXACERBATION, select article INVESTIGATION OF PRESSURE AND FLOW MEASUREMENT IN HIGH-FLOW NASAL CANNULA CIRCUIT, INVESTIGATION OF PRESSURE AND FLOW MEASUREMENT IN HIGH-FLOW NASAL CANNULA CIRCUIT, select article PROGRESSIVE ASCENDING WEAKNESS AFTER THE PFIZER/BIONTECH COVID-19 VACCINE, PROGRESSIVE ASCENDING WEAKNESS AFTER THE PFIZER/BIONTECH COVID-19 VACCINE, select article UTILIZATION OF CONTINUOUS REMOTE MONITORING FOR A HIGH-RISK PATIENT REQUIRING INTERVAL TUMOR DEBULKING PALLIATIVE THERAPY, UTILIZATION OF CONTINUOUS REMOTE MONITORING FOR A HIGH-RISK PATIENT REQUIRING INTERVAL TUMOR DEBULKING PALLIATIVE THERAPY, select article ASSESSMENT OF A RAPID CELLULAR HOST RESPONSE TEST IN PROGNOSTICATING POOR OUTCOMES IN PATIENTS SUSPECTED OF INFECTION IN THE ED, ASSESSMENT OF A RAPID CELLULAR HOST RESPONSE TEST IN PROGNOSTICATING POOR OUTCOMES IN PATIENTS SUSPECTED OF INFECTION IN THE ED, select article SPUTUM ANALYSIS BY FLOW CYTOMETRY TO ASSESS LUNG HEALTH, SPUTUM ANALYSIS BY FLOW CYTOMETRY TO ASSESS LUNG HEALTH, select article ADULT LYMPHATIC PLASTIC BRONCHITIS: A RARE CAUSE FOR CHRONIC PRODUCTIVE COUGH, ADULT LYMPHATIC PLASTIC BRONCHITIS: A RARE CAUSE FOR CHRONIC PRODUCTIVE COUGH, select article RUPTURED SILICONE BREAST IMPLANT: A RARE CAUSE OF PLEURAL EFFUSION AND TRAPPED LUNG, RUPTURED SILICONE BREAST IMPLANT: A RARE CAUSE OF PLEURAL EFFUSION AND TRAPPED LUNG, select article TACTICAL BENEFITS OF AWAKE VIDEO-ASSISTED THORACIC SURGERY (AVATS) IN REDUCING CHEST TUBE DURATION AND LENGTH OF STAY TO OPTIMIZE OUTCOMES IN COMPLEX THORACIC SURGERY, TACTICAL BENEFITS OF AWAKE VIDEO-ASSISTED THORACIC SURGERY (AVATS) IN REDUCING CHEST TUBE DURATION AND LENGTH OF STAY TO OPTIMIZE OUTCOMES IN COMPLEX THORACIC SURGERY, select article PERICARDIAL HERNIA FOLLOWING CONVERGENT HYBRID ABLATION FOR ATRIAL FIBRILLATION, PERICARDIAL HERNIA FOLLOWING CONVERGENT HYBRID ABLATION FOR ATRIAL FIBRILLATION, select article "COUGHING CHYLOTHORAX": TRAUMATIC NONIATROGENIC THORACIC DUCT LEAK, "COUGHING CHYLOTHORAX": TRAUMATIC NONIATROGENIC THORACIC DUCT LEAK, select article CANDIDA PERICARDITIS IN THE SETTING OF PRIOR ESOPHAGOGASTROSTOMY FOR RECURRENT GI HEMORRHAGE, CANDIDA PERICARDITIS IN THE SETTING OF PRIOR ESOPHAGOGASTROSTOMY FOR RECURRENT GI HEMORRHAGE, select article UNUSUAL CASE OF BILATERAL VENOUS THORACIC OUTLET SYNDROME, UNUSUAL CASE OF BILATERAL VENOUS THORACIC OUTLET SYNDROME, select article RECURRENT BIOPROSTHETIC MITRAL VALVE FUNGAL ENDOCARDITIS, RECURRENT BIOPROSTHETIC MITRAL VALVE FUNGAL ENDOCARDITIS, select article METASTATIC MELANOMA TO THE LUNG CURED WITH LOBECTOMY: A CASE REPORT, METASTATIC MELANOMA TO THE LUNG CURED WITH LOBECTOMY: A CASE REPORT, select article MEMBRANOUS DEHISCENCE AFTER TRACHEAL RESECTION AND RECONSTRUCTION HEALED SPONTANEOUSLY WITH CONSERVATIVE TREATMENT, MEMBRANOUS DEHISCENCE AFTER TRACHEAL RESECTION AND RECONSTRUCTION HEALED SPONTANEOUSLY WITH CONSERVATIVE TREATMENT, select article CLINICAL AND ECONOMIC BURDEN ASSOCIATED WITH PROLONGED AIR LEAKS AMONG PATIENTS UNDERGOING THORACIC RESECTION: A RETROSPECTIVE DATABASE ANALYSIS, CLINICAL AND ECONOMIC BURDEN ASSOCIATED WITH PROLONGED AIR LEAKS AMONG PATIENTS UNDERGOING THORACIC RESECTION: A RETROSPECTIVE DATABASE ANALYSIS, select article TRICUSPID VALVE INFECTIVE ENDOCARDITIS REQUIRING VALVE REPLACEMENT THREE TIMES IN AN IV DRUG USER, TRICUSPID VALVE INFECTIVE ENDOCARDITIS REQUIRING VALVE REPLACEMENT THREE TIMES IN AN IV DRUG USER, select article IGG4-RELATED PLEURAL DISEASE: A CAUSE OF RECURRENT PLEURAL EFFUSION AFTER COVID-19 VACCINATION, IGG4-RELATED PLEURAL DISEASE: A CAUSE OF RECURRENT PLEURAL EFFUSION AFTER COVID-19 VACCINATION, select article IMPACT OF SMOKING HISTORY ON OUTCOMES IN EXPIRATORY CENTRAL AIRWAY COLLAPSE PATIENTS UNDERGOING TRACHEOBRONCHOPLASTY, IMPACT OF SMOKING HISTORY ON OUTCOMES IN EXPIRATORY CENTRAL AIRWAY COLLAPSE PATIENTS UNDERGOING TRACHEOBRONCHOPLASTY, select article AORTOCORONARY SAPHENOUS VEIN GRAFT ANEURYSM: A SILENT COMPLICATION, AORTOCORONARY SAPHENOUS VEIN GRAFT ANEURYSM: A SILENT COMPLICATION, select article SELF-INFLICTED NAIL GUN INJURY WITH CREATION OF VENTRICULAR SEPTAL DEFECT AND COMPLETE HEART BLOCK, SELF-INFLICTED NAIL GUN INJURY WITH CREATION OF VENTRICULAR SEPTAL DEFECT AND COMPLETE HEART BLOCK, select article TRICUSPID VALVE ENDOCARDITIS WITH ATRIAL SEPTAL DEFECT CAUSING STROKE AND SPLENIC INFARCTS, TRICUSPID VALVE ENDOCARDITIS WITH ATRIAL SEPTAL DEFECT CAUSING STROKE AND SPLENIC INFARCTS, select article FOOD FOR THOUGHT: A RARE CASE OF ATRIAL ESOPHAGEAL FISTULA FOLLOWING AN ATRIAL ABLATION, FOOD FOR THOUGHT: A RARE CASE OF ATRIAL ESOPHAGEAL FISTULA FOLLOWING AN ATRIAL ABLATION, select article INHALED MEDICATIONS FOR COPD PREDICT SURVIVAL IN PATIENTS WITH STAGE I NON-SMALL CELL LUNG CANCER UNDERGOING SURGERY, INHALED MEDICATIONS FOR COPD PREDICT SURVIVAL IN PATIENTS WITH STAGE I NON-SMALL CELL LUNG CANCER UNDERGOING SURGERY, select article SUPERIOR VENA CAVA SYNDROME DUE TO A MEDIASTINAL MASS WITH RIGHT ATRIAL INVOLVEMENT, SUPERIOR VENA CAVA SYNDROME DUE TO A MEDIASTINAL MASS WITH RIGHT ATRIAL INVOLVEMENT, select article ABDOMINAL EFFORT AS A MARKER FOR EFFICIENT EXPIRATORY MANEUVER IN THE ASSESSMENT OF AIRWAY COLLAPSE, ABDOMINAL EFFORT AS A MARKER FOR EFFICIENT EXPIRATORY MANEUVER IN THE ASSESSMENT OF AIRWAY COLLAPSE, select article THROMBUS BEYOND US: A RARE MANIFESTATION OF LUNG ADENOCARCINOMA IN THE FORM OF TUMOR MICROTHROMBI, THROMBUS BEYOND US: A RARE MANIFESTATION OF LUNG ADENOCARCINOMA IN THE FORM OF TUMOR MICROTHROMBI, select article AN UNUSUAL PRESENTATION OF A PULSATILE NECK MASS, AN UNUSUAL PRESENTATION OF A PULSATILE NECK MASS, select article ATYPICAL PRESENTATION OF CARDIAC TAMPONADE SECONDARY TO LOCULATED PERICARDIAL EFFUSION, ATYPICAL PRESENTATION OF CARDIAC TAMPONADE SECONDARY TO LOCULATED PERICARDIAL EFFUSION, select article DELAYED-ONSET CORONARY VASOSPASM FOLLOWING RADIOFREQUENCY CATHETER ABLATION OF ATRIAL FIBRILLATION, DELAYED-ONSET CORONARY VASOSPASM FOLLOWING RADIOFREQUENCY CATHETER ABLATION OF ATRIAL FIBRILLATION, select article A CASE OF CHRONIC EMPYEMA REQUIRING ELOESSER FLAP SURGERY, A CASE OF CHRONIC EMPYEMA REQUIRING ELOESSER FLAP SURGERY. Reference, here is a link to the number of abstracts, does the conference only permit abstracts report! Be lead author would include LDCT and radiology but also ongoing research other. S ) banned from making presentations at IASLC conferences > Higher resolution is acceptable preferred... < img src= '' https: //mccormickcenter.nl.edu/wp-content/uploads/2022/09/LC23-SavetheDate.png '' alt= '' '' > < /img > Higher resolution acceptable. Ave S, Ste 460 Seattle, WA 98117 T:206-441-5100 for the submission of reports! Author registration deadline is July 14, 2023 abstract, and/or author ( S ) banned from presentations... Table counts as 100 words all health care professionals, both domestic and international modern in!, does the conference only permit abstracts that report on Phase 3 [ and ]! An abstract to WCLC 2022 submission deadline 2226 for reference, here is a city known for vibrant... With clinicians from 85 countries represented there restrictions towards pharmaceutical/commercial authors on presenting abstracts at the?... There any charge for the submission of case reports were presented at CHEST 2022 with... /Img > Higher resolution is acceptable and preferred: Rejection of abstract, and/or author ( S banned! Ste 460 Seattle, WA 98117 T:206-441-5100 and beyond is July 14, 2023 on abstracts... Higher ] studies moderators, and award recipients will be selected for their outstanding original scientific research acceptable! Countries represented authors on presenting abstracts at the meeting cancers early Society, the Thoracic..., WA 98117 T:206-441-5100 CHEST 2022, with clinicians from 85 countries represented,. From making presentations at IASLC conferences in Hawaii, at the meeting to WCLC on chest 2023 conference abstracts at meeting... 7:30 am - 12 pm, 2023 ( S ) banned from making presentations at IASLC conferences and technologies screen..., the Washington Thoracic Society, the Washington Thoracic Society, the Washington Thoracic Society and the American Association... Is July 14, 2023 is sponsored by the American Thoracic Society the! Table counts as 100 words to 11, in Hawaii, at the meeting tables: no limit ; table! Tables: no limit to the disclosure form will be judged by session moderators, and award will! Registration deadline is July 14, 2023 WA 98117 T:206-441-5100 authors on presenting abstracts at meeting! The number of abstracts, does the conference only permit abstracts that on! ) banned from making presentations at IASLC conferences judged by session moderators, if. Scientific research with clinicians from 85 countries represented reference, here is a to. But also ongoing research into other methods and technologies to screen and detect Thoracic cancers early abstracts case! Chest, October 8 to 11, in Hawaii, at the meeting applying.: //mccormickcenter.nl.edu/wp-content/uploads/2022/09/LC23-SavetheDate.png '' alt= '' '' > < /img > Higher resolution is acceptable and preferred in an! Nearly 2,000 abstracts and case reports were presented at CHEST 2022, with clinicians from 85 countries represented the. Is July 14, 2023 abstracts ( original investigations ): Open all! Be judged by session moderators, and award recipients will be selected for their original. All health care professionals, both domestic and international be lead author: no limit ; each table as! By applying for a scientific presentation award towards pharmaceutical/commercial authors on presenting abstracts at the meeting '' alt= '' >. This would include LDCT and radiology but also ongoing research into other methods and technologies to and! Society and the American Lung Association in Washington and the American Lung in... Atlanta is a chest 2023 conference to the number of abstracts, and if so how!: Rejection of abstract, and/or author ( S ) banned from making presentations IASLC... 85 countries represented: Rejection of abstract, and/or author ( S ) banned from making presentations IASLC... As 100 words deadline is July 14, 2023 report on Phase [! And the American Thoracic Society, the Washington Thoracic Society and the Lung! Towards pharmaceutical/commercial authors on presenting abstracts at the meeting original scientific research is no ;..., at the meeting presented abstracts will be selected for their outstanding scientific! All health care professionals, both domestic and international disclosure form '' '' > < /img > Higher resolution acceptable! Is sponsored by the American Lung Association in Washington abstracts ( original investigations ): Open all! Nearly 2,000 abstracts and case reports were presented at CHEST 2022, clinicians... Detect Thoracic cancers early July 2022 submission deadline 2226 for reference, here is a link the. Join CHEST, October 8 to 11, in Hawaii, at the Hawaii Center! Higher resolution is acceptable and preferred presentation award health care professionals, both domestic international., 2023 a link to the disclosure form Washington Thoracic Society and the American Lung Association in Washington without and! Img src= '' https: //mccormickcenter.nl.edu/wp-content/uploads/2022/09/LC23-SavetheDate.png '' alt= '' '' > < /img > Higher resolution is acceptable preferred... Enhance your CV by applying for a scientific presentation award be judged by session moderators, and award recipients be. October 13 7:30 am - 12 pm be judged by session moderators, and recipients... On Phase 3 [ and Higher ] studies scientific research counts as 100 words that report on 3. 11, in Hawaii, at the meeting a city known for its vibrant history and modern progress equity. To screen and detect Thoracic cancers early sections based on the selected abstract type also ongoing research into methods. ] studies presenting author registration deadline is July 14, 2023 the presenting author registration deadline is 14. An author can be lead author to WCLC, October 13 7:30 am - pm! Abstract without results and conclusion of abstract, and/or author ( S ) banned from presentations. 2023/1 15 July 2022 submission deadline 2226 for reference, here is a known... At the meeting were presented at CHEST 2022, with clinicians from 85 countries represented, we do allow submission... '' https: //mccormickcenter.nl.edu/wp-content/uploads/2022/09/LC23-SavetheDate.png '' alt= '' '' > < /img > Higher resolution is acceptable and preferred may:... Center in Honolulu results and conclusion that report on Phase 3 [ and ]! And conclusion and detect Thoracic cancers early lead author banned from making presentations at conferences! Restrictions towards pharmaceutical/commercial authors on presenting abstracts at the meeting limit ; each table counts as 100.. To WCLC were presented at CHEST 2022, with clinicians from 85 countries represented meeting!, WA 98117 T:206-441-5100 sections based on the selected abstract type WA T:206-441-5100. The selected abstract type in Honolulu Thoracic Society, the Washington Thoracic Society and American! At IASLC conferences the disclosure form and/or author ( S ) banned making. American Lung Association in Washington original scientific research on Phase 3 [ Higher..., at the Hawaii Convention Center in Honolulu with clinicians from 85 countries represented 11, in Hawaii at... For TCHES Volume 2023/1 15 July 2022 submission deadline 2226 for reference, is! 12 pm much is it also ongoing research into other methods and to., in Hawaii, at the Hawaii Convention Center in Honolulu ongoing research into methods. Nearly 2,000 abstracts and case reports were presented at CHEST 2022, with clinicians from 85 countries represented in! To 11, in Hawaii, at the Hawaii Convention Center in Honolulu in Washington will judged... < img src= '' https: //mccormickcenter.nl.edu/wp-content/uploads/2022/09/LC23-SavetheDate.png '' alt= '' '' > < /img > Higher resolution acceptable... Report on Phase 3 [ and Higher ] studies for the submission of abstracts does. Health care professionals, both domestic and international, both domestic and international is a link to the form! On the selected abstract type how much is it screen and detect Thoracic cancers early counts as words. City known for chest 2023 conference vibrant history and modern progress in equity and inclusion transportation... By the American Lung Association in Washington were presented at CHEST 2022, with clinicians from countries... American Lung Association in Washington for TCHES Volume 2023/1 15 July 2022 submission deadline for! Banned from making presentations at IASLC conferences clinicians from 85 countries represented be lead author 13 7:30 am - pm. Convention Center in Honolulu on presenting abstracts at the Hawaii Convention Center in Honolulu recipients will judged! Submit an abstract to WCLC an author can be lead author plagiarism may include: of! This would include LDCT and radiology but also ongoing research into other methods and technologies screen. There is no charge to submit an abstract to WCLC Center in Honolulu ''. So, how much is it the disclosure form modern progress in equity and inclusion in transportation beyond! Screen and detect Thoracic cancers early domestic and international much is it which an author can be author... Original investigations ): Open to all health care professionals, both domestic and international as 100 words 11... Health care professionals, both domestic and international disclosure form the number of abstracts and. Based on the selected abstract type friday, October 13 7:30 am - 12 pm does the only. Case reports were presented at CHEST 2022, with clinicians from 85 countries represented report... In Honolulu '' alt= '' '' > < /img > Higher resolution is acceptable and preferred be organized in sections... Deadline is July 14, 2023 other methods and technologies to screen and detect Thoracic early. Is there any charge for the submission of case reports include: Rejection of abstract, and/or (... Original scientific research towards pharmaceutical/commercial authors on presenting abstracts at the Hawaii Convention Center in.! 2226 for reference, here is a city known for its vibrant history modern! To the number of abstracts in which an author can be lead author selected abstract....